Vertex Ventures HC
Finance · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
76 S Park St, San Francisco, California,...Phone Number
(650) 285-5224Website
www.vertexventureshc.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
2
1
1
1
1
About Vertex Ventures HC
Vertex Ventures HC is a healthcare and life sciences venture capital fund that invests in various sectors including biopharmaceuticals, medical devices, and digital health services. The firm focuses on companies at all stages of development, aiming to improve health and quality of life through innovative therapeutic approaches. With a global presence and expertise, Vertex Ventures HC collaborates with exceptional entrepreneurs and industry partners to create value for shareholders and patients. The fund is part of the Vertex global network, which enhances its ability to support portfolio companies across multiple regions.Explore more
Vertex Ventures HC Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Vertex Ventures HC your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Vertex Ventures HC is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Vertex Ventures HC had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Vertex Ventures HC, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Vertex Ventures HC has new funding data
Congratulate Masked Content for being promoted to Masked Content at Vertex Ventures HC
Product Launch: Get notified when Vertex Ventures HC launches new products
Check if Vertex Ventures HC has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Vertex Ventures HC recently announced quarterly report
Recommended Actions
Find VP level buyers at Vertex Ventures HC
Find 2 more new buyers
Compare Similar Companies to Vertex Ventures HC
Compare insights from companies similar to Vertex Ventures HC, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Vertex Ventures HC is experiencing very low activity levels compared to other companies in the Finance sector.
What does this means?
Vertex Ventures HC is drawing exceptional interest within the Finance industry, suggesting notable developments or strong market momentum, learn more about Vertex Ventures HC.
Vertex Ventures HC Tech Stack
A closer look at the technologies used by Vertex Ventures HC
Most Recent Scoops
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
Hiring Plans
Vertex Ventures HC has more open roles in Engineering & Technical than it has had at any time in the past 12 months with an increased focus on technologies like Amazon AWS, and Python, and experience with Git, TIBCO Spotfire, Tricentis, vMotion, and ServiceNow.
Hiring Plans
Hiring Plans
Hiring Plans
Vertex Ventures HC News & Media
TORL BioTherapeutics Raises $158M in Series B-2 Financing
TORL BioTherapeutics, a Los Angeles, CA-based clinical-stage biotechnology company, raised $158M in Series B-2 funding. The round, which brought the total amount to $350M, was led by Deep Track Capital, with participation from RA Capital Management, Perceptive Advisors, and Avidity Partners as well as all existing biotechnology investors including Goldman Sachs Alternatives, UC Investments, Bristol […] The post TORL BioTherapeutics Raises $158M in Series B-2 Financing appeared first on FinSMEs.EyeBio Expands Series A to $130M
EyeBiotech, a London, UK-based clinical-stage ophthalmology biotechnology company, raised additional $65M in Series A funding. The round, which brought the total amount to $130M, saw participation form Bain Capital Life Sciences, Omega Funds and Vertex Ventures HC and from existing investors SV Health Investors, Jeito Capital, Samsara Biocapital and MRL Ventures Fund. The company intends […] The post EyeBio Expands Series A to $130M appeared first on FinSMEs.Vertex Ventures HC launches $200m third healthcare focused fund
Vertex Ventures HC launches $200m third healthcare focused fund Submitted 17/07/2023 - 11:46am Vertex Ventures HC (VVHC), a women-led global healthcare investment firm, has launched of its third and largest fund, the $200 million Fund III, which will focus on backing life sciences and medical technology companies aiming to drive innovation and improve patient outcomes. VVHC is anchored by a science-first, diversified investment strategy and is led by Managing Directors Lori Hu and Christine BrenSpyGlass Pharma Closes $90M Series C Financing
SpyGlass Pharma, an Aliso Viejo, CA-based ophthalmic therapeutics company, raised $90M in Series C funding. The round was led by RA Capital Management alongside existing investors New Enterprise Associates and Vensana Capital, as well as new investors Samsara BioCapital and Vertex Ventures HC. The company intends to use the funds to support multiple US clinical […] The post SpyGlass Pharma Closes $90M Series C Financing appeared first on FinSMEs.
Read more news
Top Finance Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Vertex Ventures HC
Sign Up For FreeTo access detailed company insights
Vertex Ventures HC is a healthcare and life sciences venture capital fund that invests in various sectors including biopharmaceuticals, medical devices, and digital health services. The firm focuses on companies at all stages of development, aiming to improve health and quality of life through innovative therapeutic approaches. With a global presen... Read More
